acu-8k_20220422.htm
false 0000002098 0000002098 2022-04-22 2022-04-22

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of report (date of earliest event reported): April 22, 2022

 

ACME UNITED CORPORATION

(Exact name of registrant as specified in its charter)

 

 

Connecticut

001-07698

06-0236700

(State or other jurisdiction

of incorporation or organization)

(Commission file number)

(I.R.S. Employer

Identification No.)

1 Waterview Dr, Shelton, Connecticut

 

06484

(Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code: (203) 254-6060

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange on which registered

Common Stock, $2.50 par value per share

 

ACU

 

NYSE American

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

 

 

 


 

ITEM 2.02. RESULTS OF OPERATIONS AND FINANCIAL CONDITION.

On April 22, 2022, Acme United Corporation (the “Company”) issued a press release announcing its financial results for the quarter ended March 31, 2022. A copy of the press release is attached as Exhibit 99.1 to this current report.

ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS.

(c)       Exhibits

 

Exhibit

Number

 

Description

99.1

 

Press release dated April 22, 2022.

104

 

Cover Page Interactive Data File (embedded within the Inline XBRL document).

 


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

ACME UNITED CORPORATION

 

 

 

By

/s/  Walter C. Johnsen

 

 

Walter C. Johnsen

 

 

Chairman and

 

 

Chief Executive Officer

 

 

 

 

Dated: April 22, 2022

 

 

 

 

 

 

 

 

 

By

/s/  Paul G. Driscoll

 

 

Paul G. Driscoll

 

 

Vice President and

 

 

Chief Financial Officer

 

 

 

 

Dated: April 22, 2022

 

acu-ex991_6.htm

Ex 99.1

 

ACME UNITED CORPORATION            NEWS RELEASE

CONTACT:Paul G. DriscollAcme United Corporation1 Waterview Drive Shelton, CT 06484

Phone: (203) 254-6060

 

FOR IMMEDIATE RELEASE   April 22, 2022

 

 

ACME UNITED REPORTS FIRST QUARTER OF 2022 RESULTS

 

SHELTON, CT – April 22, 2022 – Acme United Corporation (NYSE American: ACU) today announced that net sales for the quarter ended March 31, 2022 were $43.3 million compared to $43.5 million in the first quarter of 2021.

 

Net income was $830,000 or $0.22 per diluted share for the quarter ended March 31, 2021, compared to $2,046,000, or $0.52 per diluted share, for the comparable period last year, a decrease of 59% in net income and 58% in diluted earnings per share.  

 

Chairman and CEO Walter C. Johnsen said, “Despite strong orders, revenues in the first quarter were reduced due primarily to supply chain disruptions.  Direct import sales in which certain large, mass market customers take delivery from ports in China were affected by factory shutdowns and major port closures in China, as COVID-19 spread rapidly after the end of Chinese New Year in late February.  We were also negatively impacted by long lead times and congestion in East Coast ports of the U.S that resulted in late receipt of some goods.  The combined impact of these supply chain disruptions amounted to approximately $4.0 million of orders that could not ship.  Our gross margins were impacted by increased product costs, high ocean freight rates and demurrage fees at the ports.”

 

Mr. Johnsen continued, “We expect to ship many of the delayed orders in the second quarter, and our new incoming order rate is strong for both first aid and medical products and for school and office products.  Container prices seem to have stabilized, and some of the ports in China as well as our factories there are staffed and operating again.  Supply chain operations in the U.S. and Europe have also somewhat improved.  While the overall operating environment remains challenging, we continue to target revenues in excess of $200 million in 2022.”

 

 

 


Ex 99.1

 

For the first quarter of 2022, net sales in the U.S. segment decreased 1% compared to the same period in 2021 due to COVID-19 related supply chain disruptions.

 

European net sales for the first quarter of 2022 decreased 4% in U.S. dollars but increased 3% in local currency compared to the first quarter of 2021.

 

Net sales in Canada for the first quarter of 2022 increased 8% in both U.S. dollars and local currency compared to the same period in 2021, mainly due to higher sales of First Aid Central products, principally in the e-commerce channel.

 

Gross margin was 34.5% in the first quarter of 2022 versus 35.8% in the comparable period last year.  The decline in the quarter was primarily due to cost inflation pressures as well as higher transportation and labor costs.  Price increases partially offset the cost increases.

 

The Company’s bank debt less cash on March 31, 2022 was $46.2 million compared to $43.4 million on March 31, 2021.  During the twelve-month period ended March 31, 2022, the Company distributed $1.8 million in dividends on its common stock, repurchased $1.5 million of common stock, and received forgiveness of its PPP loan of $3.5 million.  We increased inventory during the twelve-month period by approximately $11 million to anticipate our continued growth and to be positioned to offset the impact of potential supply chain interruptions related to COVID-19. The increase also reflects higher product costs.

 

Conference Call and Webcast Information

Acme United will hold a conference call to discuss its quarterly results, which will be broadcast on Friday, April 22, 2022, at 12:00 p.m. EDT. To listen or participate in a question and answer session, dial 888-394-8218. International callers may dial 646-828-9193. The confirmation code is 6391122.  You may access the live webcast of the conference call through the Investor Relations section of the Company’s website, www.acmeunited.com. A replay may be accessed under Investor Relations, Audio Archives.

 

About Acme United

ACME UNITED CORPORATION is a leading worldwide supplier of innovative safety solutions and cutting technology to the school, home, office, hardware, sporting

 

 


Ex 99.1

goods and industrial markets. Its leading brands include First Aid Only®,  First Aid Central®,  PhysiciansCare®, Pac-Kit®,Spill Magic®, Westcott®, Clauss®, Camillus®, Cuda®, DMT®, and Med-Nap. For more information, visit www.acmeunited.com.  

 

Forward Looking Statements

The Company may from time to time make written or oral “forward-looking statements” including statements contained in this report and in other communications by the Company, which are made in good faith pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Such statements are based on our beliefs as well as assumptions made by and information currently available to us. When used in this document, words like “may,” “might,” “will,” “except,” “anticipate,” “believe,” “potential,” and similar expressions are intended to identify forward-looking statements. Actual results could differ materially from our current expectations.

 

Forward-looking statements in this report, including without limitation, statements related to the Company’s plans, strategies, objectives, expectations, intentions and adequacy of resources, are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties that may impact the Company’s business, operations and financial results, including those risks and uncertainties resulting from the global COVID-19 pandemic, future waves of COVID-19, including through the Delta and Omicron variants and any new variant strains of the underlying virus; any future pandemics; the continuing effectiveness, global availability, and public acceptance of existing vaccines; the effectiveness, availability, and public acceptance of vaccines against variant strains of potential new viruses; and the heightened impact the pandemic has on many of the risks described herein, including, without limitation, risks relating to disruptions in our supply chain, and labor shortages, any of which could materially adversely impact the Company’s ability to manufacture, source or distribute its products, both domestically and internationally.

 

These risks and uncertainties further include, without limitation, the following: (i) changes in the Company’s plans, strategies, objectives, expectations and intentions, which may be made at any time at the discretion of the Company; (ii) the impact of uncertainties in

 

 


Ex 99.1

global economic conditions, whether caused by COVID-19 or otherwise, including the impact on the Company’s suppliers and customers; (iii) additional disruptions in the Company’s supply chains, whether caused by COVID-19 or otherwise; (iv) labor shortages and related costs the Company has and may continue to incur, including costs of acquiring and training new employees and rising wages and benefits; (v) the continuing adverse impact of cost inflation; (vi) the Company’s ability to effectively manage its inventory in a rapidly changing business environment, including the additional inventory the Company acquired in anticipation of supply chain disruptions and uncertainties; (vii) changes in client needs and consumer spending habits; (viii) the impact of competition; (ix) the impact of technological changes including, specifically, the growth of online marketing and sales activity; (x) the Company’s ability to manage its growth effectively, including its ability to successfully integrate any business it might acquire; (xi) currency fluctuations; (xii) international trade policies and their impact on demand for our products and our competitive position, including the imposition of new tariffs or changes in existing tariff rates; and (xiii) other risks and uncertainties indicated from time to time in the Company’s filings with the Securities and Exchange Commission.

#    #    #

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


Ex 99.1

 

 

ACME UNITED CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

FIRST QUARTER REPORT 2022

(Unaudited)

 

 

 

Quarter Ended

 

 

Quarter Ended

 

Amounts in 000's except per share data

 

March 31, 2022

 

 

March 31, 2021

 

Net sales

 

$

43,333

 

 

$

43,525

 

Cost of goods sold

 

 

28,365

 

 

 

27,938

 

Gross profit

 

 

14,968

 

 

 

15,587

 

Selling, general and administrative expenses

 

 

13,597

 

 

 

12,619

 

Operating income

 

 

1,371

 

 

 

2,968

 

Interest expense

 

 

309

 

 

 

226

 

Interest income

 

 

(4

)

 

 

(5

)

Net interest expense

 

 

305

 

 

 

221

 

Other expense, net

 

 

(2

)

 

 

77

 

Income before income tax expense

 

 

1,068

 

 

 

2,670

 

Income tax expense

 

 

238

 

 

 

624

 

Net income

 

$

830

 

 

$

2,046

 

Shares outstanding - basic

 

 

3,521

 

 

 

3,347

 

Shares outstanding - diluted

 

 

3,848

 

 

 

3,911

 

Earnings per share - basic

 

$

0.24

 

 

$

0.61

 

Earnings per share - diluted

 

 

0.22

 

 

 

0.52

 

 

 

 


Ex 99.1

 

 

ACME UNITED CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

FIRST QUARTER REPORT 2022

(Unaudited)

 

Amounts in $000's

 

 

 

 

 

 

 

 

 

 

March 31, 2022

 

 

March 31, 2021

 

Assets

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

5,307

 

 

$

3,857

 

Accounts receivable, net

 

 

34,605

 

 

 

31,592

 

Inventories

 

 

60,716

 

 

 

49,389

 

Prepaid expenses and other current assets

 

 

3,810

 

 

 

2,477

 

Total current assets

 

 

104,438

 

 

 

87,315

 

 

 

 

 

 

 

 

 

 

Plant, property and equipment, net

 

 

23,887

 

 

 

21,138

 

Operating lease right of use asset

 

 

3,064

 

 

 

3,700

 

Intangible assets, less accumulated amortization

 

 

16,888

 

 

 

18,361

 

Goodwill

 

 

4,800

 

 

 

4,800

 

Total assets

 

$

153,077

 

 

$

135,314

 

 

 

 

 

 

 

 

 

 

Liabilities and stockholders' equity

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

Accounts payable

 

$

8,323

 

 

$

8,151

 

Operating lease liability - short term

 

 

1,009

 

 

 

932

 

Mortgage payable - short term

 

 

389

 

 

 

267

 

Other current liabilities

 

 

11,554

 

 

 

11,323

 

Total current liabilities

 

 

21,275

 

 

 

20,673

 

 

 

 

 

 

 

 

 

 

Long-term debt

 

 

40,151

 

 

 

40,626

 

Long term debt - PPP loan-

 

-

 

 

 

3,508

 

Mortgage payable - long term

 

 

10,989

 

 

 

2,844

 

Operating lease liability - long term

 

 

2,289

 

 

 

2,926

 

Other non-current liabilities

 

 

600

 

 

 

110

 

Total liabilities

 

 

75,304

 

 

 

70,687

 

Total stockholders' equity

 

 

77,773

 

 

 

64,627

 

Total liabilities and stockholders' equity

 

$

153,077

 

 

$

135,314